Amphetamine Lacing of an Internet-Marketed Neutraceutical

Nguyen, Minh H.; Ormiston, Tom; Kurani, Sanjay; Woo, Denise K.
December 2006
Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1627
Academic Journal
A 25-year-old woman presented with abdominal pain after taking an imported herbal weight-loss product. A urinary toxicology screen was positive for amphetamine, which the patient denied taking. On further investigation, the neutraceutical was found to contain an amphetamine derivative banned by the US Food and Drug Administration (FDA). Although the patient had discontinued use of the supplement before hospitalization and her symptoms steadily improved with appropriate treatment, a report was made to the FDA. Similar reports from cities across the United States prompted the FDA to confiscate shipments of the product before it could be distributed further nationally while they investigate claims against the product.


Related Articles

  • Herbal medicines.  // Reactions Weekly;1/27/2007, Issue 1136, p17 

    This article presents a case study of abdominal pain following use of an amfetamine-containing supplement. The case involves a 25-year-old obese woman who developed abdominal pain during treatment with herbal weight-loss supplement containing amfetamine. Clinical history of the patient is...

  • Herbal medicines.  // Reactions Weekly;1/20/2007, Issue 1135, p17 

    The article presents a case study of a 52-year-old woman who developed ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. After a week of taking the weight-loss supplement, the patient complained of abdominal cramping associated with the passing of...

  • Why Diet Drugs Can Be Diet Dangers. Murphy, Dee // Current Health 2;Dec2000, Vol. 27 Issue 4, p18 

    Explains the dangers of using diet pills and other weight loss preparations. INSET: Why Diet Claims: Fact or Fiction?.

  • Fen-Phen `wannabe's' crowding the weight-loss scene. Zied, Elisa S. // Environmental Nutrition;Dec97, Vol. 20 Issue 12, p2 

    Evaluates several drugs for weight reduction. Need for prescription for the combination drug phentermine and fluoxetine; Herbal origins of the Herbal Phen-Fen drug alternative; Promotion of various amino acid combinations for weight loss uses.

  • New anti-obesity drug is not for everyone.  // Mayo Clinic Health Letter;Aug1999, Vol. 17 Issue 8, p4 

    Reports on the use of the anti-obesity drug orlistat. Indications approved by the United States Food & Drug Administration; Differences from other diet drugs; Side effects; Precautionary measures in using the drug.

  • Oxedrine.  // Reactions Weekly;4/3/2010, Issue 1295/1296, p30 

    The article describes the case of a 24-year-old man who developed ST elevation myocardial infarction (STEMI) while taking oxedrine for weight loss.

  • Next generation of `diet pills' may offer hope for weight control. Hrabak, DeAnne // Environmental Nutrition;Nov94, Vol. 17 Issue 11, p1 

    Reports on health professionals' increasing focus on the use of prescription appetite suppressants or diet pills as a way to control weight permanently. Addition of diet pills to classic exercise/reduced-calorie/reduced-fat eating plans; Use of appetite suppressants in other drug treatments for...

  • Diet drugs: The next generation.  // Shape;Oct96, Vol. 16 Issue 2, p118 

    Presents a list of upcoming and US Food and Drug Administration-approved weight loss drugs. Therapeutic use; Side effects.

  • Who exactly should be taking these drugs?  // Shape;Oct96, Vol. 16 Issue 2, p118 

    Highlights the physiological effects of diet drugs, according to Pennington Biomedical Research Center executive director for science Donna Ryan. Side effects of appetite depressants; Health risks associated with obesity; Efficacy of drug pills for people with serious weight problems.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics